IBDEI3IZ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2430,0)
 ;;=EDUCATION/TRAINING GRP/IND^3^217
 ;;^UTILITY(U,$J,358.4,2431,0)
 ;;=SUPPLIES^10^217
 ;;^UTILITY(U,$J,358.4,2432,0)
 ;;=ESTABLISHED PT-OUTPT^1^218
 ;;^UTILITY(U,$J,358.4,2433,0)
 ;;=INPATIENT CARE^2^218
 ;;^UTILITY(U,$J,358.4,2434,0)
 ;;=COMMON PULMONARY DX^1^219
 ;;^UTILITY(U,$J,358.4,2435,0)
 ;;=SLEEP DISORDERS^20^219
 ;;^UTILITY(U,$J,358.4,2436,0)
 ;;=OBSTRUCTIVE SLEEP APNEA^13^219
 ;;^UTILITY(U,$J,358.4,2437,0)
 ;;=OTHER^26^219
 ;;^UTILITY(U,$J,358.4,2438,0)
 ;;=CANCER^2^219
 ;;^UTILITY(U,$J,358.4,2439,0)
 ;;=CARDIAC^3^219
 ;;^UTILITY(U,$J,358.4,2440,0)
 ;;=ENDOCRINE^4^219
 ;;^UTILITY(U,$J,358.4,2441,0)
 ;;=ENT^5^219
 ;;^UTILITY(U,$J,358.4,2442,0)
 ;;=GASTROINTESTINAL^5^219
 ;;^UTILITY(U,$J,358.4,2443,0)
 ;;=GENITOURINARY/RENAL^6^219
 ;;^UTILITY(U,$J,358.4,2444,0)
 ;;=HEMATOLOGIC/LYMPHATIC^7^219
 ;;^UTILITY(U,$J,358.4,2445,0)
 ;;=HEPATIC/BILIARY^8^219
 ;;^UTILITY(U,$J,358.4,2446,0)
 ;;=INFECTIOUS DISEASE^9^219
 ;;^UTILITY(U,$J,358.4,2447,0)
 ;;=INTERSTITIAL LUNG DISEASE^10^219
 ;;^UTILITY(U,$J,358.4,2448,0)
 ;;=MUSCULOSKELETAL^11^219
 ;;^UTILITY(U,$J,358.4,2449,0)
 ;;=SUTURES^23^219
 ;;^UTILITY(U,$J,358.4,2450,0)
 ;;=RADIATION^19^219
 ;;^UTILITY(U,$J,358.4,2451,0)
 ;;=OCCUPATIONAL^15^219
 ;;^UTILITY(U,$J,358.4,2452,0)
 ;;=PAIN^16^219
 ;;^UTILITY(U,$J,358.4,2453,0)
 ;;=PLEURAL DISEASE^17^219
 ;;^UTILITY(U,$J,358.4,2454,0)
 ;;=PSYCHIATRIC/BEHAVIORAL^18^219
 ;;^UTILITY(U,$J,358.4,2455,0)
 ;;=SKIN^22^219
 ;;^UTILITY(U,$J,358.4,2456,0)
 ;;=NEUROLOGIC^12^219
 ;;^UTILITY(U,$J,358.4,2457,0)
 ;;=OBSTRUCTIVE DISEASE^14^219
 ;;^UTILITY(U,$J,358.4,2458,0)
 ;;=VASCULAR^24^219
 ;;^UTILITY(U,$J,358.4,2459,0)
 ;;=SYMPTOMS^21^219
 ;;^UTILITY(U,$J,358.4,2460,0)
 ;;=ASPIRATION/INJECTION^1^220
 ;;^UTILITY(U,$J,358.4,2461,0)
 ;;=INJECTION MEDICATIONS^2^220
 ;;^UTILITY(U,$J,358.4,2462,0)
 ;;=ULTRASOUND^3^220
 ;;^UTILITY(U,$J,358.4,2463,0)
 ;;=NEW PATIENT^2^221
 ;;^UTILITY(U,$J,358.4,2464,0)
 ;;=ESTABLISHED PATIENT^1^221
 ;;^UTILITY(U,$J,358.4,2465,0)
 ;;=CONSULTATIONS^3^221
 ;;^UTILITY(U,$J,358.4,2466,0)
 ;;=COMMON DIAGNOSES^1^222
 ;;^UTILITY(U,$J,358.4,2467,0)
 ;;=CRYSTAL ARTHROPATHIES^2^222
 ;;^UTILITY(U,$J,358.4,2468,0)
 ;;=JOINT DISORDERS^5^222
 ;;^UTILITY(U,$J,358.4,2469,0)
 ;;=MISCELLANEOUS^6^222
 ;;^UTILITY(U,$J,358.4,2470,0)
 ;;=NERVOUS SYSTEM^7^222
 ;;^UTILITY(U,$J,358.4,2471,0)
 ;;=OSTEOARTHRITIS^8^222
 ;;^UTILITY(U,$J,358.4,2472,0)
 ;;=OSTEOMYELITIS^9^222
 ;;^UTILITY(U,$J,358.4,2473,0)
 ;;=OSTEOPOROSIS^10^222
 ;;^UTILITY(U,$J,358.4,2474,0)
 ;;=PYOGENIC ARTHRITIS^11^222
 ;;^UTILITY(U,$J,358.4,2475,0)
 ;;=SPINE DISORDERS^12^222
 ;;^UTILITY(U,$J,358.4,2476,0)
 ;;=TENDINITIS & BURSITIS^13^222
 ;;^UTILITY(U,$J,358.4,2477,0)
 ;;=VASCULAR DISORDERS^16^222
 ;;^UTILITY(U,$J,358.4,2478,0)
 ;;=VASCULITIS CONDITIONS^15^222
 ;;^UTILITY(U,$J,358.4,2479,0)
 ;;=INFECTIONS^3^222
 ;;^UTILITY(U,$J,358.4,2480,0)
 ;;=INT DERANGEMENT OF KNEE^4^222
 ;;^UTILITY(U,$J,358.4,2481,0)
 ;;=OTHER INFLAMMATORY^10.5^222
 ;;^UTILITY(U,$J,358.4,2482,0)
 ;;=VACCINATIONS^13^223
 ;;^UTILITY(U,$J,358.4,2483,0)
 ;;=INJECTION^7^223
 ;;^UTILITY(U,$J,358.4,2484,0)
 ;;=EDUCATION/TRAINING^3^223
 ;;^UTILITY(U,$J,358.4,2485,0)
 ;;=COUNSELING^2^223
 ;;^UTILITY(U,$J,358.4,2486,0)
 ;;=EVALUATIONS^4^223
 ;;^UTILITY(U,$J,358.4,2487,0)
 ;;=SPINAL INJECTION CODES^9^223
 ;;^UTILITY(U,$J,358.4,2488,0)
 ;;=SUPPLIES^10^223
 ;;^UTILITY(U,$J,358.4,2489,0)
 ;;=TREATMENT PROCEDURES^11^223
 ;;^UTILITY(U,$J,358.4,2490,0)
 ;;=TRIGGER POINT INJECTIONS^12^223
 ;;^UTILITY(U,$J,358.4,2491,0)
 ;;=HOME VISIT-ESTABLISHED PT^5^223
 ;;^UTILITY(U,$J,358.4,2492,0)
 ;;=HOME VISIT-NEW PT^6^223
